Pell Bio-Med Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,248	306.7	427.37	167.68	172.4	115.78
Short-Term Investments	201	351	479.75	938.15	536	-
Trading Asset Securities	-	-	29.06	-	-	-
Cash & Short-Term Investments	2,449	657.7	936.18	1,106	708.4	115.78
Cash Growth	138.74%	-29.75%	-15.34%	56.10%	511.84%	-
Accounts Receivable	6.33	5.07	3.75	7.61	6.05	4.5
Other Receivables	3.47	3.21	2.4	0.33	0.36	6.12
Receivables	9.8	8.27	6.15	7.94	6.41	10.62
Inventory	12.75	6.62	6.18	3.76	4.58	4.24
Prepaid Expenses	23.06	5.46	9.22	8.86	5.84	1.1
Other Current Assets	0.1	653.37	200	0.65	0.16	0.08
Total Current Assets	2,495	1,331	1,158	1,127	725.39	131.82
Property, Plant & Equipment	722.74	709.81	386.45	260.92	298.97	249.74
Long-Term Investments	0.27	0.27	0.37	0.37	0.26	0.26
Other Intangible Assets	3.08	2.93	1.89	2.4	2.71	1.47
Other Long-Term Assets	69.91	67.8	198.39	27.44	17.07	10.61
Total Assets	3,291	2,112	1,745	1,418	1,044	393.89
Accounts Payable	8.19	5.83	4.49	6.99	5.72	8.61
Accrued Expenses	-	106.49	64.12	39.74	14.58	19.19
Short-Term Debt	100	100	200	-	5	-
Current Portion of Leases	29.89	27.99	27.55	25.09	25.07	10.76
Current Unearned Revenue	-	0.02	0.02	-	-	0.75
Other Current Liabilities	121.74	68.64	25.17	17.47	6.86	4.87
Total Current Liabilities	259.82	308.97	321.35	89.3	57.24	44.18
Long-Term Leases	109.11	109.28	137.27	147.47	172.56	124.84
Other Long-Term Liabilities	0.02	0.02	-	-	-	-
Total Liabilities	368.95	418.27	458.62	236.77	229.79	169.02
Common Stock	649.13	587.98	578.43	539.43	443.65	333.76
Additional Paid-In Capital	3,678	1,910	1,804	1,449	774.25	77.38
Retained Earnings	-1,708	-1,631	-1,207	-817.85	-419.09	-188.96
Treasury Stock	-0.6	-0.8	-0.8	-0.8	-	-
Comprehensive Income & Other	42.35	555.74	5.52	-	2.13	2.69
Total Common Equity	2,661	1,422	1,180	1,170	800.94	224.86
Minority Interest	261.48	272.07	106.29	11.18	13.67	0.01
Shareholders' Equity	2,922	1,694	1,286	1,181	814.6	224.87
Total Liabilities & Equity	3,291	2,112	1,745	1,418	1,044	393.89
Total Debt	239	237.27	364.82	172.56	202.63	135.6
Net Cash (Debt)	2,210	420.43	571.36	933.27	505.77	-19.82
Net Cash Growth	230.91%	-26.41%	-38.78%	84.52%	-	-
Net Cash Per Share	37.56	7.17	10.01	20.17	12.89	-0.60
Filing Date Shares Outstanding	76.58	58.72	57.8	53.9	44.36	33.28
Total Common Shares Outstanding	76.58	58.72	57.8	53.9	44.36	33.28
Working Capital	2,235	1,022	836.38	1,038	668.15	87.64
Book Value Per Share	34.74	24.22	20.41	21.71	18.05	6.76
Tangible Book Value	2,658	1,419	1,178	1,168	798.22	223.39
Tangible Book Value Per Share	34.70	24.17	20.38	21.67	17.99	6.71
Machinery	-	310.33	95.05	90.37	81.84	75.31
Construction In Progress	-	285.99	148.34	-	-	-
Leasehold Improvements	-	104.12	86.72	86.72	86.18	86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.